Pain Management with Fentanyl Transdermal Patches

Introduction to Fentanyl Patch Dosage

• The National Comprehensive Cancer Network (NCCN) recommends calculating the patient's current 24-hour opioid requirement, then converting to morphine equivalents using established conversion tables, and selecting the corresponding fentanyl patch strength 1

Dosage Calculation and Conversion

• Calculate the total 24-hour requirement of the patient's current opioid medication, and use the conversion table to find the corresponding fentanyl patch strength based on the 24-hour morphine equivalent dose, as suggested by the NCCN 1
• For medications not listed in the table, convert to equianalgesic oral morphine dose using established conversion ratios, such as 20mg/day oral oxymorphone × 3 = 60mg/day oral morphine equivalent 1
• The conversion ratio for oral oxycodone to oral morphine is 1:1.5-2, according to the NCCN guidelines 1
• The following conversion table can be used for transdermal fentanyl:

Fentanyl Patch Strength and Dosage

• Use the conversion table to find the corresponding fentanyl patch strength, for example, 60mg/day oral oxycodone (or 60mg/day oral morphine equivalent) corresponds to a 25mcg/h fentanyl patch, as recommended by the NCCN 1
• For doses exceeding 100mcg/h, multiple patches may be used 1
• A 25mcg/h fentanyl patch is approximately equivalent to 60mg/day oral morphine, which helps determine appropriate breakthrough medication dosing during weaning 1

Administration and Monitoring

• Pain should be relatively well controlled on short-acting opioids before starting fentanyl patches, with a high strength of evidence based on clinical trials 1
• Prescribe breakthrough medication (short-acting opioid) at 10-15% of the 24-hour morphine equivalent dose, especially during the first 24-48 hours 1
• Wait at least 3 days before increasing the dose to allow for steady-state plasma levels, and adjust patch dosage based on breakthrough medication requirements after steady state is reached (2-3 days) 1
• Monitor the patient closely for respiratory depression, especially in the first 24-48 hours, and adjust the dose after at least 3 days if needed, based on breakthrough medication requirements, with a moderate strength of evidence based on clinical experience 1

Safety Precautions

• Avoid applying heat (heating pads, electric blankets, fever) as it accelerates fentanyl absorption and increases overdose risk, as warned by the NCCN 1
• Avoid abrupt discontinuation of fentanyl patches, as it can lead to severe withdrawal symptoms, and remind patients to avoid heat sources (heating pads, hot baths) as they increase fentanyl absorption and risk of overdose 1
• Early symptoms of withdrawal include anxiety, restlessness, yawning, sweating, and rhinorrhea, while later symptoms include nausea, vomiting, diarrhea, abdominal cramps, muscle aches, and dilated pupils 1

Weaning and Discontinuation

• The NCCN recommends a gradual reduction in fentanyl patch dose by 25% every 6 days, with monitoring for withdrawal symptoms and provision of breakthrough pain medication as needed, to minimize withdrawal symptoms and maintain adequate pain control 1
• Individualize the weaning schedule based on duration of use, and consider comorbidities such as cardiac or psychiatric conditions, which may require more gradual tapering 1
• Monitor breakthrough medication usage to guide adjustments to the weaning schedule, and prescribe short-acting opioid (e.g., immediate-release morphine or oxycodone) at 10-15% of the 24-hour morphine equivalent dose, such as 5-10mg oral morphine every 4 hours as needed for a 25mcg patch (≈60mg oral morphine/day) 1